Doctors Note Logo

Published on: 2/7/2026

Metoclopramide Over 65: Watching for Movement Risks

In adults over 65, metoclopramide requires extra caution because it can trigger movement disorders such as tardive dyskinesia, with risk increasing at higher doses and especially with use beyond 12 weeks; it is listed in the Beers Criteria. Watch for early signs like facial or tongue movements, restlessness, stiffness, or new confusion and drowsiness, use the lowest effective dose for the shortest time, and contact your clinician promptly if symptoms appear rather than stopping the drug on your own. There are several factors to consider, and important safety steps and alternatives that may change your next steps, so see the complete guidance below.

answer background

Explanation

Metoclopramide Over 65: Watching for Movement Risks

Metoclopramide is a prescription medicine commonly used to treat nausea, vomiting, heartburn, and delayed stomach emptying (gastroparesis). For many people, it can be helpful and effective. However, in adults over age 65, metoclopramide deserves extra care—especially because of its potential to cause movement-related side effects.

This article explains what those risks are, why they matter more with age, how to spot early warning signs, and how to use metoclopramide as safely as possible. The goal is to inform—not alarm—so you can make confident decisions with your healthcare team.


Why Age Matters with Metoclopramide

As we age, our bodies process medications differently. Changes in kidney function, brain chemistry, and sensitivity to drugs can increase the chance of side effects. Older adults are also more likely to take multiple medications, which raises the risk of interactions.

Because of these factors, metoclopramide is listed in the Beers Criteria, a respected guide that highlights medications that may pose higher risks for adults over 65. The main concern is its effect on the brain's dopamine system, which helps control movement.


Understanding Movement Risks

What Are Movement Disorders?

Movement disorders are conditions that affect how the body moves. With metoclopramide, the most discussed risk is tardive dyskinesia, but other movement-related effects can occur as well.

These effects are neurologic, meaning they involve the brain and nervous system.

Common Movement-Related Side Effects

Some movement symptoms can appear early, while others develop after longer use. Not everyone experiences them, but the risk increases with:

  • Higher doses
  • Longer treatment duration
  • Older age
  • Female sex
  • Diabetes or other neurologic conditions

Possible movement-related side effects include:

  • Involuntary facial movements (lip smacking, chewing motions)
  • Tongue movements or difficulty controlling the tongue
  • Blinking or eye movements that are hard to stop
  • Hand or arm jerking
  • Restlessness or an urge to keep moving (akathisia)
  • Muscle stiffness or slowed movements

These symptoms may start subtly and can be easy to overlook at first.


Tardive Dyskinesia: The Most Serious Concern

Tardive dyskinesia (TD) is a condition involving repetitive, involuntary movements, often of the face and mouth. It can also affect the arms, legs, or torso.

Key Points About Tardive Dyskinesia

  • The risk increases with longer use, especially beyond 12 weeks
  • Older adults are at higher risk
  • Symptoms may persist even after stopping the medication
  • Early recognition improves outcomes

Because of this risk, the U.S. Food and Drug Administration (FDA) recommends that metoclopramide generally not be used for longer than 12 weeks, unless the benefit clearly outweighs the risk.


Other Neurologic Side Effects to Watch For

In addition to movement disorders, metoclopramide can cause other brain-related side effects that may be more noticeable in older adults:

  • Confusion or mental fog
  • Drowsiness or fatigue
  • Dizziness
  • Mood changes, such as anxiety or low mood
  • Sleep disturbances

While these are not movement disorders, they can still affect safety—especially increasing the risk of falls.


When Metoclopramide May Still Be Appropriate

Despite the risks, metoclopramide can be appropriate for some older adults when:

  • Symptoms are severe and affecting nutrition or quality of life
  • Other treatments have not worked
  • The dose is kept as low as possible
  • The duration is short and closely monitored

In conditions like diabetic gastroparesis, short-term use under medical supervision may offer meaningful relief.


Practical Safety Tips for Adults Over 65

If you or a loved one is prescribed metoclopramide, these steps can help reduce risk:

Use the Lowest Effective Dose

  • Ask if a lower dose could work
  • Avoid increasing the dose without medical advice

Limit Duration

  • Confirm how long the medication is intended to be used
  • Review the need for ongoing therapy regularly

Monitor for Early Symptoms

  • Check for subtle changes in facial movements or restlessness
  • Ask family members to observe, as they may notice changes first

Review Other Medications

  • Some drugs increase the risk of movement side effects
  • Bring a full medication list to each appointment

What to Do If You Notice Symptoms

If new movement symptoms appear:

  • Do not stop metoclopramide abruptly unless instructed
  • Contact the prescribing clinician promptly
  • Early evaluation can help prevent symptoms from worsening

If you're experiencing new or unusual symptoms and want to better understand what might be happening before your next appointment, consider using this free Medically approved LLM Symptom Checker Chat Bot to help organize your concerns and prepare for a more informed conversation with your healthcare provider.


Talking With Your Doctor: Key Questions to Ask

Having an open conversation can make treatment safer and more effective. Consider asking:

  • Why is metoclopramide the best option for me?
  • How long should I take it?
  • What movement symptoms should I watch for?
  • Are there safer alternatives for my condition?
  • How often should we reassess the need for this medication?

Always speak to a doctor right away about any symptoms that feel serious, sudden, or life-threatening, such as severe confusion, uncontrolled movements, or trouble breathing.


Alternatives and Supportive Strategies

Depending on the condition being treated, alternatives may include:

  • Dietary changes (smaller, more frequent meals)
  • Adjusting meal timing
  • Other medications with different risk profiles
  • Non-drug approaches recommended by a specialist

A healthcare provider can help tailor options to individual needs, preferences, and risk factors.


Balancing Benefit and Risk

Metoclopramide is not "bad" medicine—but it is a medicine that requires respect and monitoring, especially in adults over 65. Understanding movement risks empowers patients and caregivers to catch problems early and work closely with clinicians to stay safe.

Used thoughtfully, for the right reasons, and for the right length of time, metoclopramide may provide meaningful relief. The key is awareness, communication, and regular review.

If you have concerns or notice changes, do not wait. Speak to a doctor or qualified healthcare professional to discuss whether metoclopramide is still the best choice for you or your loved one.

(References)

  • * Sempere P, Segura-Jiménez J, Martínez-Sanchís M, García-Gimeno F, Pérez-Lluch R, Lajara-Blesa B. Metoclopramide-induced tardive dyskinesia in older adults: A review of the literature. Rev Esp Geriatr Gerontol. 2021 May-Jun;56(3):169-173. PMID: 33500216.

  • * Safdar O, Al-Arifi MN, Al-Aqeel SA, Al-Jedai A, Al-Ammary M. Extrapyramidal Adverse Drug Reactions with Metoclopramide: A Population-Based Study. J Clin Pharmacol. 2017 Jul;57(7):902-908. PMID: 28028751.

  • * Kuo YF, Tan A, Alsaad H, Sharma S, Singh S, Shen H, Markides KS. Risk of extrapyramidal symptoms and gastrointestinal side effects among older adults prescribed metoclopramide for nausea/vomiting or gastroparesis. Clin Ther. 2014 Jun 1;36(6):901-908. PMID: 24793635.

  • * Al-Hussainy A, El-Mallakh RS. Metoclopramide and Tardive Dyskinesia: A Review. J Clin Psychopharmacol. 2023 Feb;43(1):26-30. PMID: 36622320.

  • * Ganzini L, O'Sullivan PS. Metoclopramide in the elderly: a review of the risks and benefits. Drugs Aging. 2003;20(1):19-27. PMID: 12518933.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.